Annual report pursuant to Section 13 and 15(d)

Acquisitions (Tables)

 v2.3.0.11
Acquisitions (Tables)
 12 Months Ended
Jun. 30, 2011
Estimated Fair Values of Assets Acquired and Liabilities Assumed

 The following table summarizes the estimated fair values of the assets acquired and liabilities assumed as a result of the fiscal 2011 acquisitions (in thousands):

 

     Boston
Biochem		      Tocris  

Current assets

    $ 1,738       $ 33,837   

Intangible assets

      4,300         48,425   

Goodwill

      1,500         61,365   

Equipment

      484         1,233   
  

 

 

     

 

 

  

Total assets acquired

      8,022         144,860   

Current liabilities

      134         1,800   

Deferred income taxes

      0         19,182   
  

 

 

     

 

 

  

Net assets acquired

    $ 7,888       $ 123,878   
  

 

 

     

 

 

  

Cash paid, net of cash acquired

    $ 7,888       $ 123,878   
  

 

 

     

 

 

  
Unaudited Pro Forma Results of Acquisition as if Tocris Acquisition Had Occurred at the Beginning of Fiscal 2010

The following table contains unaudited pro forma results for the years ended June 30, 2011 and 2010, as if the Tocris acquisition had occurred at the beginning of fiscal 2010. Pro forma results of operations have not been presented for the Boston Biochem acquisition since the effects were not material to the Company. The results of operations of all acquired businesses have been included in the Company’s Consolidated Statement of Earnings since the dates of acquisition. Amounts are in thousands, except per share data.

 

     2011      2010  
     Reported      Pro forma
(Unaudited)		      Reported      Pro forma
(Unaudited)		  

Net sales

    $ 289,962       $ 305,860       $ 269,047       $ 286,913   

Net earnings

      112,302         118,641         109,776         113,558   

Net earnings per share:

            

Basic

      3.03         3.20         2.95         3.05   

Diluted

      3.02         3.19         2.94         3.04